To further test the effects of combination drugs (ZEB1 activator and Rosiglitazone) on inducing a cancer to adipose transition, we performed bioinformatics analysis to the RNA‐seq data from our experiments (Supporting Information, Supplemental methods). This evidence concerns the gene ZEB1 and cancer.